000			01847 a2200493 4500
005			20250514042046.0
264		0	_c20020905
008			200209s 0 0 eng d
022			_a0026-895X
024	7		_a10.1124/mol.62.3.722 _2doi
040			_aNLM _beng _cNLM
100	1		_aRuby, Carl E
245	0	0	_a2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected. _h[electronic resource]
260			_bMolecular pharmacology _cSep 2002
300			_a722-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntibodies _ximmunology
650	0	4	_aBinding Sites
650	0	4	_aCD40 Antigens _ximmunology
650	0	4	_aCell Nucleus _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aDNA-Binding Proteins _xmetabolism
650	0	4	_aDendritic Cells _xdrug effects
650	0	4	_aI-kappa B Proteins
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNF-KappaB Inhibitor alpha
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aOncogene Proteins v-rel _xmetabolism
650	0	4	_aPeptide Hydrolases _xmetabolism
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPolychlorinated Dibenzodioxins _xpharmacology
650	0	4	_aProtein Binding
650	0	4	_aReceptors, Aryl Hydrocarbon _xmetabolism
650	0	4	_aTeratogens _xpharmacology
650	0	4	_aTranscription Factor RelA
650	0	4	_aTransfection
650	0	4	_aTumor Necrosis Factor-alpha _xmetabolism
700	1		_aLeid, Mark
700	1		_aKerkvliet, Nancy I
773	0		_tMolecular pharmacology _gvol. 62 _gno. 3 _gp. 722-8
856	4	0	_uhttps://doi.org/10.1124/mol.62.3.722 _zAvailable from publisher's website
999			_c12063936 _d12063936